Holzgerlingen, Germany — Curetis AG, an innovative molecular
diagnostics company focusing on the development and commercialization of
in-vitro diagnostic products for infectious diseases, today announced the
presentation of its Unyvero™ System and the Unyvero™ P50 Pneumonia Cartridge
during the European Congress of Clinical Microbiology and Infectious Diseases
(ECCMID) in London.
The showcasing will be accompanied by the Curetis-sponsored Integrated
Symposium “Bacterial Pneumonia and Emerging Antibiotic Resistance”, which will
focus on pneumonia-causing pathogens, their respective antibiotic resistances,
and the relevance of multiplexed molecular diagnostic testing. The event will
be chaired by clinical microbiologist and molecular diagnostics specialist
Prof. Christine Ginocchio (North Shore-LIJ Health System School of Medicine,
New York), and Prof. Keith Klugman (Emory
University, Atlanta), the worlds premier expert on
antibiotic resistance among pneumococcal bacteria.
The Unyvero™ System is a versatile hardware platform for the
detection of a broad panel of bacteria and antibiotic resistances from a single
sample in one run. It processes a disposable cartridge providing the necessary
reagents to complete the analysis from sample to report. The Unyvero™ P50
Cartridge is the first cartridge developed by Curetis AG and focuses on
pathogen as well as antibiotic resistance testing for pneumonia. Each cartridge
handles one patient sample and simultaneously analyzes 39 DNA targets. Results
are available within less than 4 hours.
“We are very happy to introduce our product during the
ECCMID conference in the presence of eminent specialists in pneumonia
infections, antibiotic resistance and molecular diagnostics,” said Oliver
Schacht, CEO of Curetis. “Severe acute infections and growing antibiotic
resistances are a major burden for today`s health care systems and treatment is
often impaired by insufficient, slow diagnostics. By providing a novel technology
for the fast, precise and automated diagnosis of infectious disease agents and
their antibiotic resistances, we hope to contribute to improved clinical
outcomes and to limit the risk of even further increasing antibiotic
resistances in the population.”
The symposium will take place on April 1, 2012, from 4pm to
6pm in Capital Suite H (level 3) at the international exhibition and convention
centre ExCeL, London.
Symposium speakers include Prof. Jean-Louis Vincent (Erasmus
University, Brussels),
Prof. David Livermore (University of East Anglia), and Prof. Ingo Autenrieth (University of Tuebingen). Talks will be followed by a
panel discussion on the clinical relevance of faster molecular testing with
contributions by Prof. Christine Ginocchio and Antonio Torres (University
Clinic, Barcelona).
Following the event, Curetis will host a presentation of the Unyvero™ System,
including an address by Prof. Carl Erik Nord, Karolinska University Hospital
and a reception (6pm, meeting rooms 24/25). Further information about the
symposium and the speakers are available here.
Curetis AG will exhibit its products and technology from
March 31 to April 3, 2012, during the ECCMID conference (hall S10 Exhibition,
level 1, booth 213). The event will take place at ExCeL London. Curetis AG is
proud to be Silver Medal Sponsor of the 2012 ECCMID.
